Enliven Therapeutics, Inc.
public$ELVN View Live Feed →
Total Raised
--
Contracts
--
Patents
--
PAC Giving
--
Government Contracts & Awards
No recent government contracts or awards found.
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
No recent news or market intelligence found for this entity.
Congressional Trades in $ELVN
No disclosed congressional trades found in $ELVN.
Insider Trades (Form 4)
SELLCHIEF FINANCIAL OFFICER
Hohl Benjamin
$320,91312,036 shares Oct 21, 2026
SELLCHIEF MEDICAL OFFICER
Collins Helen Louise
$204,74210,000 shares Oct 21, 2026
GRANTDirector
BALL KRISTINE M
23,394 shares Oct 16, 2026
SELLDirector
Garland J. Scott
$807,82926,000 shares Oct 5, 2026
SELLDirector
Derynck Mika K
$11,282,554317,590 shares Aug 7, 2026
SELLCHIEF FINANCIAL OFFICER
Hohl Benjamin
$319,4397,090 shares Jul 21, 2026
SELLCHIEF MEDICAL OFFICER
Collins Helen Louise
$275,77310,000 shares Jul 21, 2026
SELL10% Owner
OrbiMed Genesis GP LLC
$39,014,046860,123 shares Jun 24, 2026
Key People
BALL KRISTINE M
Director
BoardInsider
Garland J Scott
Director
BoardInsider
Derynck Mika K
Director
BoardInsider
Collins Helen Louise
CHIEF MEDICAL OFFICER
BoardInsider
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Insider
OrbiMed Genesis GP LLC
10% Owner
BoardInsider
Kunkel Lori Anne
Director
BoardInsider
Political Giving
No disclosed PAC contributions found for this entity.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro